Mineralys Therapeutics, Inc. (MLYS) Tops Q2 EPS by 41c
Tweet
Share
E-mailGet Alerts MLYS Hot Sheet
Join SI Premium – FREE
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) reported Q2 EPS of ($0.31), $0.41 better than the analyst estimate of ($0.72).
For earnings history and earnings-related data on Mineralys Therapeutics, Inc. (MLYS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BMO starts chip stocks coverage: Here are its preferred picks
- Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
